Shuaijie Lou

Curcumin analog JM-2 alleviates diabetic cardiomyopathy inflammation and remodeling by inhibiting the NF-κB pathway.

Weiwei Zhu, Wu Luo, Xue Han, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A small-molecule JNK inhibitor JM-2 attenuates high-fat diet-induced non-alcoholic fatty liver disease in mice.

Weiwei Zhu, Bin Yang, Wu Luo, 2022, International immunopharmacology.

Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a.

Gaozhi Chen, Weiwei Zhu, Wu Luo, 2024, Biochimica et biophysica acta. Molecular basis of disease.

JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytes

Wu Luo, Shiqi Liang, Shuaijie Lou, 2024, Cellular and molecular life sciences : CMLS.

Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88.

Yi Wang, Weiwei Zhu, Wu Luo, 2023, International immunopharmacology.